To Compare Efficacy & Safety of CT-P16 & EU-Approved Avastin as First-Line

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04122833` - Impact of Concomitant Genetic Alterations in EGFR Mutated Adenocarcinoma by NGS Analysis: A Multicenter Study
Recruiting	`NCT04557449` - Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors	Phase 1/Phase 2
Terminated	`NCT04027946` - LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)	Phase 2
Not yet recruiting	`NCT05079022` - ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas	Phase 1/Phase 2
Completed	`NCT02616211` - An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors
Completed	`NCT03184571` - Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC	Phase 2
Recruiting	`NCT05550961` - APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch
Active, not recruiting	`NCT05292859` - Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Not yet recruiting	`NCT05565677` - Prognostic Value of Lung Cancer MicroAnatomy in 3D
Completed	`NCT05252676` - Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)
Recruiting	`NCT03838588` - The Tracking Molecular Evolution for NSCLC (T-MENC) Study
Recruiting	`NCT04105270` - RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial	Phase 2
Not yet recruiting	`NCT02946216` - ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC	N/A
Completed	`NCT00073398` - Vaccine Treatment for Advanced Non-Small Cell Lung Cancer	Phase 1/Phase 2
Recruiting	`NCT04770688` - Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib	Phase 1/Phase 2
Completed	`NCT04165759` - HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)
Completed	`NCT04086680` - The Detection of EGFR Mutations in Liquid Based Cytology Samples
Completed	`NCT01362790` - SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma	Phase 1/Phase 2
Recruiting	`NCT06299163` - NM32-2668 in Adult Patients With Selected Advanced Solid Tumors	Phase 1
Recruiting	`NCT03298763` - Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer	Phase 1/Phase 2

NCT number	NCT03676192
Study type	Interventional
Source	Celltrion
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	December 19, 2018
Completion date	August 2023

To Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms